Top Pharmaceuticals companies in Sweden by EBIT

This ranking features the top 38 Pharmaceuticals companies in Sweden ranked by EBIT, totaling a EBIT of USD 348.26 M, for July 04, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Pharmaceuticals company in Sweden has the highest EBIT ?

The Pharmaceuticals company in Sweden with the highest EBIT is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 506.25 M.

Which Pharmaceuticals company in Sweden has the lowest EBIT ?

The Pharmaceuticals company in Sweden with the lowest EBIT is BioInvent International AB (publ) (Stockholm Stock Exchange: BINV.ST) at USD -38.58 M.

What are the top 10 Pharmaceuticals companies in Sweden by EBIT ?

The top 10 Pharmaceuticals companies in Sweden by EBIT are Swedish Orphan Biovitrum AB (publ), Vimian Group AB (publ), Camurus AB (publ), BioGaia AB (publ), Magle Chemoswed Holding AB (publ), Kontigo Care AB (publ), Aptahem AB (publ), OncoZenge AB (publ), Pila Pharma AB (publ) and Scandinavian Real Heart AB (Publ).

What are the bottom 10 Pharmaceuticals companies in Sweden by EBIT ?

The bottom 10 Pharmaceuticals companies in Sweden by EBIT are BioInvent International AB (publ), Moberg Pharma AB (publ), Egetis Therapeutics AB (publ), Oncopeptides AB (publ), Xspray Pharma AB (publ), BioArctic AB (publ), Vicore Pharma Holding AB (publ), Diamyd Medical AB (publ), Infant Bacterial Therapeutics AB (publ) and Mendus AB (publ).